AML WITH GENE MUTATIONS
Clinical trials for AML WITH GENE MUTATIONS explained in plain language.
Never miss a new study
Get alerted when new AML WITH GENE MUTATIONS trials appear
Sign up with your email to follow new studies for AML WITH GENE MUTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat leukemia: experimental drug enters human trials
Disease control Recruiting nowThis early-stage study tests a new drug, ZE46-0134, in adults with a specific form of acute myeloid leukemia (AML) that has come back or not responded to standard treatment. The main goals are to find a safe dose and see if the drug can help control the disease. About 150 partici…
Matched conditions: AML WITH GENE MUTATIONS
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
New hope for AML patients: targeted drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests a new drug called revumenib added to standard chemotherapy and a targeted therapy (midostaurin) for people with a specific genetic type of acute myeloid leukemia (AML). The goal is to find a safe dose and see how well it works to put the cancer into r…
Matched conditions: AML WITH GENE MUTATIONS
Phase: PHASE1 • Sponsor: Richard Stone, MD • Aim: Disease control
Last updated May 26, 2026 08:22 UTC